JILL MILLER: Open Payments
NPI 1811148422 · SAEGERTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 22 payments from 11 companies in 2025. Trend: 2023 $1,318 · 2024 $684 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 4 | $105 |
| ABBVIE INC. | 4 | $76 |
| Lilly USA, LLC | 3 | $69 |
| Novo Nordisk Inc | 3 | $57 |
| Alkermes, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: SUBLOCADE, JARDIANCE, Ozempic, VIVITROL, VRAYLAR, QULIPTA, MOUNJARO, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
